0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-25.95%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-48.58%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-122.15%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-122.15%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-112.71%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-111.92%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-111.92%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
5.84%
Share count expansion well above 0425.HK's 0.53%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
5.85%
Diluted share count expanding well above 0425.HK's 0.46%. Michael Burry would fear significant dilution to existing owners' stakes.
-1.18%
Dividend reduction while 0425.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
21.66%
Positive OCF growth while 0425.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
22.08%
Positive FCF growth while 0425.HK is negative. John Neff would see a strong competitive edge in net cash generation.
-40.24%
Negative 10Y revenue/share CAGR while 0425.HK stands at 220.17%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-52.05%
Negative 5Y CAGR while 0425.HK stands at 53.82%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
20.63%
3Y revenue/share CAGR above 1.5x 0425.HK's 10.76%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-6853.77%
Negative 10Y OCF/share CAGR while 0425.HK stands at 82.10%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-29.54%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-75.23%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-114.02%
Negative 10Y net income/share CAGR while 0425.HK is at 103.76%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-118.06%
Negative 5Y net income/share CAGR while 0425.HK is 7.46%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-148.19%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
90.48%
10Y equity/share CAGR at 50-75% of 0425.HK's 151.93%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
-2.50%
Negative 5Y equity/share growth while 0425.HK is at 54.61%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
38.48%
3Y equity/share CAGR above 1.5x 0425.HK's 23.49%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-24.01%
Cut dividends over 10 years while 0425.HK stands at 331.15%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-60.78%
Negative 5Y dividend/share CAGR while 0425.HK stands at 2.44%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-60.06%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-20.45%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
6.44%
Inventory growth well above 0425.HK's 9.92%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-4.93%
Negative asset growth while 0425.HK invests at 3.65%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
8.83%
BV/share growth above 1.5x 0425.HK's 2.38%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
7.92%
Debt growth far above 0425.HK's 10.30%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
15.24%
We increase R&D while 0425.HK cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-27.52%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.